These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 16286124

  • 1. Impact of obesity on prostate cancer recurrence after radical prostatectomy: data from CaPSURE.
    Bassett WW, Cooperberg MR, Sadetsky N, Silva S, DuChane J, Pasta DJ, Chan JM, Anast JW, Carroll PR, Kane CJ.
    Urology; 2005 Nov; 66(5):1060-5. PubMed ID: 16286124
    [Abstract] [Full Text] [Related]

  • 2. Impact of positive surgical margins on prostate cancer recurrence and the use of secondary cancer treatment: data from the CaPSURE database.
    Grossfeld GD, Chang JJ, Broering JM, Miller DP, Yu J, Flanders SC, Henning JM, Stier DM, Carroll PR.
    J Urol; 2000 Apr; 163(4):1171-7; quiz 1295. PubMed ID: 10737489
    [Abstract] [Full Text] [Related]

  • 3. Impact of obesity on the utility of preoperative prostate-specific antigen velocity to predict for relapse after prostatectomy: a report from the SEARCH database.
    King CR, Freedland SJ, Terris MK, Kane CJ, Amling CL, Aronson WJ, Presti JC.
    Urology; 2007 May; 69(5):921-6. PubMed ID: 17482935
    [Abstract] [Full Text] [Related]

  • 4. Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases.
    Freedland SJ, Sun L, Kane CJ, Presti JC, Terris MK, Amling CL, Moul JW, Aronson WJ.
    BJU Int; 2008 Sep; 102(8):969-74. PubMed ID: 18691175
    [Abstract] [Full Text] [Related]

  • 5. Body mass index trends and role of obesity in predicting outcome after radical prostatectomy.
    Motamedinia P, Korets R, Spencer BA, Benson MC, McKiernan JM.
    Urology; 2008 Nov; 72(5):1106-10. PubMed ID: 18602142
    [Abstract] [Full Text] [Related]

  • 6. Body mass index and prostate-specific antigen failure following brachytherapy for localized prostate cancer.
    Efstathiou JA, Skowronski RY, Coen JJ, Grocela JA, Hirsch AE, Zietman AL.
    Int J Radiat Oncol Biol Phys; 2008 Aug 01; 71(5):1302-8. PubMed ID: 18262732
    [Abstract] [Full Text] [Related]

  • 7. Adjuvant radiotherapy in prostate cancer: predictors of prostate-specific antigen recurrence from the CaPSURE database.
    Macdonald OK, D'Amico AV, Sadetsky N, Shrieve DC, Carroll PR.
    Urology; 2007 Jul 01; 70(1):106-10. PubMed ID: 17656218
    [Abstract] [Full Text] [Related]

  • 8. Is preoperative serum prostate-specific antigen level significantly related to clinical recurrence after radical retropubic prostatectomy for localized prostate cancer?
    Haukaas SA, Halvorsen OJ, Daehlin L, Hostmark J, Akslen LA.
    BJU Int; 2006 Jan 01; 97(1):51-5. PubMed ID: 16336328
    [Abstract] [Full Text] [Related]

  • 9. The ratio of oleic-to-stearic acid in the prostate predicts biochemical failure after radical prostatectomy for localized prostate cancer.
    Kositsawat J, Flanigan RC, Meydani M, Choi YK, Freeman VL.
    J Urol; 2007 Dec 01; 178(6):2391-6; discussion 2396. PubMed ID: 17936811
    [Abstract] [Full Text] [Related]

  • 10. Effect of obesity on prostate-specific antigen recurrence after radiation therapy for localized prostate cancer as measured by the 2006 Radiation Therapy Oncology Group-American Society for Therapeutic Radiation and Oncology (RTOG-ASTRO) Phoenix consensus definition.
    Stroup SP, Cullen J, Auge BK, L'Esperance JO, Kang SK.
    Cancer; 2007 Sep 01; 110(5):1003-9. PubMed ID: 17614338
    [Abstract] [Full Text] [Related]

  • 11. Prognostic value of preoperative serum cell-free circulating DNA in men with prostate cancer undergoing radical prostatectomy.
    Bastian PJ, Palapattu GS, Yegnasubramanian S, Lin X, Rogers CG, Mangold LA, Trock B, Eisenberger M, Partin AW, Nelson WG.
    Clin Cancer Res; 2007 Sep 15; 13(18 Pt 1):5361-7. PubMed ID: 17875764
    [Abstract] [Full Text] [Related]

  • 12. Percentage of positive biopsy cores, preoperative prostate-specific antigen (PSA) level, pT and Gleason score as predictors of PSA recurrence after radical prostatectomy: a multi-institutional outcome study in Japan.
    Yokomizo A, Murai M, Baba S, Ogawa O, Tsukamoto T, Niwakawa M, Tobisu K, Kinukawa N, Naito S.
    BJU Int; 2006 Sep 15; 98(3):549-53. PubMed ID: 16925752
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Interval from prostate biopsy to radical prostatectomy: effect on PSA, Gleason sum, and risk of recurrence.
    Shibata A, Mohanasundaram UM, Terris MK.
    Urology; 2005 Oct 15; 66(4):808-13. PubMed ID: 16230143
    [Abstract] [Full Text] [Related]

  • 17. Should we replace the Gleason score with the amount of high-grade prostate cancer?
    Vis AN, Roemeling S, Kranse R, Schröder FH, van der Kwast TH.
    Eur Urol; 2007 Apr 15; 51(4):931-9. PubMed ID: 16935413
    [Abstract] [Full Text] [Related]

  • 18. Time to prostate-specific antigen nadir after androgen suppression therapy for postoperative or postradiation PSA failure and risk of prostate cancer-specific mortality.
    Chung CS, Chen MH, Cullen J, McLeod D, Carroll P, D'Amico AV.
    Urology; 2008 Jan 15; 71(1):136-40. PubMed ID: 18242382
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Obese men have higher-grade and larger tumors: an analysis of the duke prostate center database.
    Freedland SJ, Bañez LL, Sun LL, Fitzsimons NJ, Moul JW.
    Prostate Cancer Prostatic Dis; 2009 Jan 15; 12(3):259-63. PubMed ID: 19581922
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.